Corrado Garibaldi: The Contrarian Trader Who Profits When Others Panic
Corrado Garibaldi—better known in finance circles as Lord Conrad—has carved a reputation as a maverick trader who thrives on going against the grain. His mantra? 'Buy the fear. Sell the euphoria.'
The Unconventional Path to Trading Mastery
Unlike Wall Street's typical Ivy League-educated financiers, Garibaldi is a self-made trader with no formal finance background. An Italian native, he entered the markets out of necessity, driven by a desire to take control of his financial future.
'I never studied economics or attended business school,' he admits. 'I learned by doing—making mistakes, refining strategies, and realizing that most people lose money because they follow the crowd.'
The Contrarian Edge: Why 99.9999% of Traders Are Wrong
Garibaldi's core philosophy is rooted in contrarian investing—a strategy that capitalizes on market overreactions.
'When everyone is buying, I'm selling. When panic sets in, I'm buying,' he says. 'The masses are almost always wrong at extremes. That's where the real opportunities lie.'
This approach has allowed him to profit from major market swings, whether during the crypto crashes of 2022 or the AI stock frenzy of 2024.
Two Sides of the Same Coin: Trader by Day, Investor by Night
Garibaldi operates in two distinct modes:
As a trader, he's a speed-focused tactician, scalping the Nasdaq and executing swing trades with military precision.
As an investor, he's a patient wealth-builder, holding long-term positions in giants like Apple, Microsoft, and Tesla while diversifying into bonds and crypto.
His portfolio strategy? 99% long-term holdings, 1% high-octane trading—a balance that maximizes growth while keeping risk in check.
The Trader's Mindset: Why Psychology Beats IQ
For Garibaldi, trading isn't just about charts—it's about mastering fear and greed.
'Most traders fail because they let emotions drive decisions,' he says. 'The key is to stay mechanical. Follow the plan, not the panic.'
He enforces strict rules:
✔ Never risk more than 1% on a single trade
✔ Always use stop-losses
✔ Ignore hype—trade the data, not the narrative
2025 and Beyond: Adapt or Die
In an era of AI-driven markets and geopolitical volatility, Garibaldi remains agile—constantly refining strategies and engaging with traders worldwide via social media.
'Markets change. If you're not learning, you're losing,' he warns.
Final Word: The Slow Road to Trading Success
For aspiring traders, Garibaldi's advice is refreshingly honest:
'This isn't a get-rich-quick game. Consistency beats luck. Small, smart gains compound over time—that's how real wealth is built.'
Want to see his strategies in action? Visit Trading Invest Celebrity Italy.
TIME BUSINESS NEWS
Hashtags
Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
Yahoo
17 minutes ago
- Yahoo
NVE Schedules Conference Call on First Quarter Results
EDEN PRAIRIE, Minn., July 16, 2025--(BUSINESS WIRE)--NVE Corporation (Nasdaq: NVEC) announced that it plans to release its financial results for the quarter ended June 30, 2025 on Wednesday, July 23, 2025 after the close of the Nasdaq Regular Market. The company will hold its quarterly conference call later that day at 4:00 p.m. Central Time. The quarterly call will be webcast live in a listen-only mode through the Investor Events page of NVE's Website ( An archive of the call will also be available on NVE's Website. To dial into the conference call, parties should call 855-552-4463 inside the United States, or 312-479-9427 and enter Meeting ID 7749 14 3539. Parties may request to ask questions on the call by dialing in or logging into NVE is a leader in the practical commercialization of spintronics, a nanotechnology that relies on electron spin rather than electron charge to acquire, store, and transmit information. The company manufactures high-performance spintronic products including sensors and couplers that are used to acquire and transmit data. Statements we use that relate to future plans, events, financial results or performance are forward-looking statements that are subject to certain risks and uncertainties including, among others, the risk factors listed from time to time in our filings with the SEC, including our Annual Report on Form 10-K for the fiscal year ended March 31, 2025. View source version on Contacts investor@
Yahoo
17 minutes ago
- Yahoo
India eyes global quantum computer push — and QpiAI is its chosen vehicle
QpiAI, an Indian startup that claims to integrate AI and quantum computing for enterprise use cases, has raised $32 million in a new funding round co-led by the Indian government as the company aims to expand its presence and develop utility-scale quantum computers for markets around the world. The Indian government's $750 million National Quantum Mission has co-led QpiAI's all-equity Series A round, alongside Avataar Ventures, at a post-money valuation of $162 million. The funding reflects India's broader push to establish itself as a quantum computing power. Launched in 2023, the National Quantum Mission is an Indian government initiative that views quantum computing as both an economic opportunity and a national security imperative. The program aims to help develop intermediate-scale quantum computers with 50–1,000 physical qubits within 8 years across platforms including superconducting and photonics. It also targets the development of satellite-based quantum communications, inter-city quantum distribution, multi-node quantum networks, magnetometers, and the design and synthesis of quantum materials, including superconductors, semiconductor structures, and topological materials for quantum device fabrication. QpiAI is one of eight startups selected by the National Quantum Mission, each receiving an initial grant of up to $3.5 million. Among these companies, the Bengaluru-headquartered startup, which has subsidiaries in the U.S. and Finland, says it has built India's first full-stack quantum computer, called QpiAI-Indus, which it launched in April with 25 superconducting qubits. Founded in 2019, QpiAI says it integrates quantum computing and AI to provide optimization capabilities in areas such as manufacturing, industrial, transportation, finance, pharma, and materials. The startup says it has developed specialized software, along with its proprietary hardware, to support real-world quantum applications in fields such as materials science and drug discovery. 'Quantum can really make sure AI is robust,' said QpiAI founder and CEO Nagendra Nagaraja in an interview. The startup views simulation, drug synthesis, and material discovery as some of the key use cases where the combination of AI and quantum could provide a competitive edge. 'Because the design space of a quantum chip is very, very big, and to actually get optimal qubits, which is important when we integrate thousands of qubits to get logical qubits for error correction, AI plays a bigger role there,' Nagaraja told TechCrunch. QpiAI plans to launch its 64-qubit quantum computer in November, with availability to customers expected by the second or third quarter of next year, Nagaraja said. The company is also working to start manufacturing its quantum hardware locally in 2026. Currently, it assembles 80% of its machines in-house. QpiAI employs a 100-person team, comprising 25 PhDs from international institutions or from Indian institutes. About 50 of its employees are based in India. The company says it has around 20 customers in India and the U.S., including the Indian government, which uses its infrastructure to test algorithms. According to the company, QpiAI has been profitable at EBITDA level for the past three years, with approximately 60% gross margins and 20% to 30% net margins, Nagaraja told TechCrunch. With the fresh funding, QpiAI plans to enter new markets including Singapore and the Middle East. It also aims to allocate funds for its local manufacturing plans and scale its operations to develop a 100-logical qubit system by 2030. In June of last year, QpiAI raised $6.5 million in a pre-Series A round led by Yournest and SVCL at a post-money valuation of around $30 million. Nagaraja told TechCrunch that QpiAI has a three- to four-year runway, even without accounting for its profitability. He also said the startup is considering an initial public offering in either 2026 or 2027. The National Quantum Mission's support extends beyond QpiAI. The Indian government's program is also backing startups such as QNuLabs (working on quantum-safe networks), Dimira Technologies (cryogenic cables), Prenishq (diode-laser systems), and QuPrayog (optical atomic clocks). It has also supported Quanastra (cryogenic systems and superconducting detectors), Pristine Diamonds (diamond-based sensing materials), and Quan2D Technologies (single-photon detectors for quantum communication). 'We plan to continue to support home-grown product companies like QpiAI to help them expand into large enterprises and position India as global leaders in quantum technologies,' said Ajai Chowdhry, chairman of India's National Quantum Mission, in a prepared statement.
Yahoo
17 minutes ago
- Yahoo
Sarepta Therapeutics Stock Is Surging After The Bell: What's Going On?
Sarepta Therapeutics Inc (NASDAQ:SRPT) shares are soaring in Wednesday's after-hours session after the company announced a strategic restructuring and cost-cutting measures. What To Know: After the market close on Wednesday, Sarepta Therapeutics introduced a strategic restructuring plan that involves focusing on high-value, high-impact programs and supporting long-term financials. Sarepta said it initiated immediate changes to reduce operating expenses, including a 36% workforce reduction and a pipeline reprioritization. The changes are expected to drive approximately $400 million in annual cost reductions and lower the company's average annual research and development expenses and selling, general and administrative expenses to between $800 million and $900 million starting in 2026. Sarepta anticipates $100 million in cost savings through the end of 2025. 'Faced with environmental changes, we have decided to act decisively, implementing a focused strategy to ensure Sarepta remains a vibrant, financially enduring, patient-centric organization dedicated to improving the lives of those with rare genetic diseases,' said Doug Ingram, CEO of Sarepta Therapeutics. 'These changes will ensure we remain a financially strong and profitable organization built on a sharpened and focused strategy.' In connection with the announcement, Sarepta reported preliminary financial results for the second quarter. The company said it expects to report second-quarter net product revenue of $513 million. Sarepta had $850 million of cash, cash equivalents, restricted cash and investments as of June 30. The company also announced several new executive leadership changes, including the appointment of Ian Estepan as president and COO and Ryan Wong as CFO. Louise Rodino-Klapac was named president of R&D and technical operations, Rachael Potter was appointed as chief scientific officer and Patrick Moss was named chief commercial officer. SRPT Price Action: Sarepta Therapeutics shares were up 38.08% at $25.38 in after-hours trading at the time of publication Wednesday, according to Benzinga Pro. Read Next: How 340B Drug Discounts Are Driving Up Medicaid Costs By Billions Photo: Shutterstock. Up Next: Transform your trading with Benzinga Edge's one-of-a-kind market trade ideas and tools. Click now to access unique insights that can set you ahead in today's competitive market. Get the latest stock analysis from Benzinga? SAREPTA THERAPEUTICS (SRPT): Free Stock Analysis Report This article Sarepta Therapeutics Stock Is Surging After The Bell: What's Going On? originally appeared on © 2025 Benzinga does not provide investment advice. All rights reserved.
